Search results for "Highlights"
Drinking coffee may reduce risk of death, disease progression in patients with advanced colorectal cancer, study finds
An editorial noted coffee's unique role in diet, as it is widely consumed as a daily habit, and explained why a potential link between coffee consumption and colorectal cancer is biologically plausible.
https://gastroenterology.acponline.org/archives/2020/09/25/1.htm
25 Sep 2020
Anti-TNF therapy did not reduce IBD hospitalizations or intestinal resections in Ontario
Infliximab may have been used inappropriately in Crohn's disease and underused in ulcerative colitis, according to the authors of an analysis of hospitalizations, intestinal resections, and drug costs related to inflammatory bowel disease (IBD).
https://gastroenterology.acponline.org/archives/2019/06/28/3.htm
28 Jun 2019
Combination therapy for IBD carries higher infection risk than monotherapy
Monotherapy for inflammatory bowel disease (IBD) with an immunosuppressive agent was associated with a lower risk of serious infection than a tumor necrosis factor (TNF) antagonist alone or an anti-TNF plus an immunosuppressive agent, according to a meta-analysis.
https://gastroenterology.acponline.org/archives/2019/03/22/2.htm
22 Mar 2019
ACIP updates hepatitis A vaccination recommendations
The Advisory Committee on Immunization Practices (ACIP) changed its recommendations regarding vaccination of patients with chronic liver disease, pregnant women, and those treated with blood products for clotting disorders, among other revisions.
https://gastroenterology.acponline.org/archives/2020/07/24/1.htm
24 Jul 2020
Effects of gastric acid suppression drugs on COVID-19 outcomes still unclear
A meta-analysis didn't find an association between famotidine use and severe disease or death from COVID-19, and the association of these outcomes with proton-pump inhibitors varied by study type.
https://gastroenterology.acponline.org/archives/2021/02/26/1.htm
26 Feb 2021
Statins associated with lower risk for postcolonoscopy colorectal cancer
The primary outcome of the retrospective cohort study was postcolonoscopy colorectal cancer within three years, defined as colorectal cancer diagnosed within six and 36 months after negative findings on index colonoscopy.
https://gastroenterology.acponline.org/archives/2019/03/22/3.htm
22 Mar 2019
Beta-blockers linked to better outcomes in some patients with cirrhosis
Decompensation-free survival improved in patients with cirrhosis and portal hypertension who received beta-blockers versus placebo, largely due to a decrease in ascites.
https://gastroenterology.acponline.org/archives/2019/04/26/3.htm
26 Apr 2019
Cirrhosis puts COVID-19 patients at higher risk of hospitalization, death
An analysis of U.S. veterans with and without cirrhosis who were tested for SARS-CoV-2 this spring found a 30-day mortality rate of 17.1% in patients with both conditions, compared to 2.3% in those with neither COVID-19 nor cirrhosis.
https://gastroenterology.acponline.org/archives/2020/12/18/1.htm
18 Dec 2020
ACG lowers suggested age for colorectal cancer screening in updated guidelines
The American College of Gastroenterology (ACG) continues to recommend colorectal cancer screening in average-risk adults ages 50 to 75 years but now also suggests it in those ages 45 to 49 years.
https://gastroenterology.acponline.org/archives/2021/03/26/1.htm
26 Mar 2021
Use of drugs, nondrug treatments for functional bowel disorders analyzed
One study found that nonpharmacologic interventions are underused in ambulatory care visits for functional bowel disorders, while another found that patients with irritable bowel disease and their insurers have financial incentives to favor differing treatments.
https://gastroenterology.acponline.org/archives/2020/10/23/1.htm
23 Oct 2020